Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

SELL
$0.58 - $0.86 $95,990 - $142,330
-165,500 Reduced 90.88%
16,600 $10,000
Q4 2021

Feb 15, 2022

SELL
$0.73 - $1.28 $1,241 - $2,176
-1,700 Reduced 0.92%
182,100 $148,000
Q3 2021

Nov 16, 2021

BUY
$0.77 - $4.91 $9,856 - $62,848
12,800 Added 7.49%
183,800 $146,000
Q2 2021

Aug 16, 2021

BUY
$2.18 - $4.66 $372,780 - $796,860
171,000 New
171,000 $790,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.